Variant report
Variant | esv3439931 |
---|---|
Chromosome Location | chr6:23870273-23874471 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201723481 | chr6:23870275-23870276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552880685 | chr6:23870298-23870299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556674189 | chr6:23870355-23870356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182089569 | chr6:23870419-23870420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566231997 | chr6:23870421-23870422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539569545 | chr6:23870450-23870451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186377835 | chr6:23870459-23870460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576116517 | chr6:23870460-23870461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543417744 | chr6:23870506-23870507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555731030 | chr6:23870543-23870544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568604161 | chr6:23870560-23870561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139822500 | chr6:23870582-23870583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12665727 | chr6:23870606-23870607 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs188425137 | chr6:23870614-23870615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533174323 | chr6:23870615-23870616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143205450 | chr6:23870628-23870629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs56189051 | chr6:23870634-23870635 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs9466952 | chr6:23870656-23870657 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs549045757 | chr6:23870674-23870675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567243502 | chr6:23870681-23870682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529592212 | chr6:23870689-23870690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577439366 | chr6:23870730-23870731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs62402268 | chr6:23870773-23870774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549606148 | chr6:23870775-23870776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79173695 | chr6:23870776-23870777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78329024 | chr6:23870789-23870790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76549410 | chr6:23870790-23870791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557937735 | chr6:23870856-23870857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573348670 | chr6:23870870-23870871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9460932 | chr6:23870876-23870877 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs370083036 | chr6:23870925-23870926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539656957 | chr6:23870933-23870934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs180746312 | chr6:23870935-23870936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556003363 | chr6:23871013-23871014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145394272 | chr6:23871015-23871016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573984566 | chr6:23871020-23871021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374067710 | chr6:23871029-23871030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186655441 | chr6:23871041-23871042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190998984 | chr6:23871060-23871061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182010613 | chr6:23871075-23871076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560669921 | chr6:23871108-23871109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527762520 | chr6:23871112-23871113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78877215 | chr6:23871207-23871208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200871839 | chr6:23871209-23871210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370491327 | chr6:23871211-23871212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534682555 | chr6:23871224-23871225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186942003 | chr6:23871239-23871240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs1511472 | chr6:23871249-23871250 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs545226745 | chr6:23871251-23871252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563468926 | chr6:23871269-23871270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:23869400-23870400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr6:23869800-23871200 | Enhancers | Fetal Brain Male | brain |
3 | chr6:23870400-23877200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr6:23870600-23871000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr6:23870600-23871200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr6:23870600-23871200 | Enhancers | Brain Germinal Matrix | brain |
7 | chr6:23870600-23871400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr6:23870600-23872200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr6:23870800-23871200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr6:23871200-23872200 | Weak transcription | Fetal Brain Male | brain |
11 | chr6:23871200-23873600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr6:23871200-23874600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
13 | chr6:23871200-23874800 | Weak transcription | Brain Germinal Matrix | brain |
14 | chr6:23871400-23874400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr6:23872200-23872600 | Enhancers | Fetal Brain Male | brain |
16 | chr6:23872200-23872600 | Active TSS | Fetal Lung | lung |
17 | chr6:23872200-23872600 | ZNF genes & repeats | Pancreas | Pancrea |
18 | chr6:23872200-23873200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr6:23873000-23874800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
20 | chr6:23873000-23876400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
21 | chr6:23873200-23873600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr6:23873600-23876200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
23 | chr6:23873600-23881800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr6:23874000-23876000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
25 | chr6:23874400-23876000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |